Sheba Medical Center Pioneers New Accelerated AI Cancer Diagnostics Platform Shortening Time to Diagnosis

Ramat Gan, Israel – Sheba Medical Center, Israel’s largest medical center, announced the deployment of a new accelerated, AI-powered cancer diagnostics research platform to improve patient diagnosis, treatment and outcomes. The platform enables the integration of AI technology developed by Sheba in addition to solutions created by innovative digital health start-ups.

One of the first AI solutions to be deployed was developed by Imagene, an emerging leader in AI-based precision oncology, incorporating an algorithm to identify actionable biomarkers of non-small cell lung cancer. The algorithm is directly applied to a digitized image of a conventionally stained pathology slide and can then, within minutes, identify the presence of actionable biomarkers in the tumor, thus providing crucial information for diagnostic and therapeutic decisions. The solution essentially shortens diagnostic time from three weeks to minutes, enabling patients to begin treatment earlier.

“We have reached another significant milestone in digital pathology with this ability to detect biomarkers by AI. The use of deep learning algorithms is changing the world of diagnosis, and in certain cases can drastically shorten the cost and time to treatment. I am excited to hear about the growing number of patients who were able to receive rapid diagnoses and treatment using our new service” said Prof. Iris Barshack, Head of the Pathology Institute at Sheba Medical Center.

This latest advancement in cancer diagnostics builds on the significant progress Sheba’s Pathology Institute has made in recent years. In 2019, the pathology lab at the hospital went fully digital, using computer screens for diagnosis instead of microscopes. Once the Pathology lab turned fully digital, the team worked in collaboration with Imagene who developed a rapid AI-based molecular profiling algorithm to identify actionable biomarkers from the digital biopsy image alone.

“AI is already transforming the field of healthcare and oncology specifically. ARC is proud to be a part of this collaborative achievement in precision medicine that will have a significant impact in global health,” said Prof. Eyal Zimlichman, Chief Transformation Officer and Chief Innovation Officer at Sheba Medical Center and Director and Founder of ARC Innovation.


 

About Sheba Medical Center

The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel  Hashomer is generating global impact through its medical care, research and healthcare transformation.  Sheba’s City of Health boasts an acute-care hospital, rehabilitation hospital, research and innovation  hubs, medical simulation center and center for disaster response on one comprehensive campus in the  center of Israel. A university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv  University, Sheba is shaping the future of healthcare, educating the next generation of care providers.  Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from  all over the world and consistently providing the highest-level medical care to all in need. Sheba has  been ranked a top-ten hospital in the world by Newsweek four years in a row (2019, 2020, 2021, 2022).

For more information, visit: https://sheba-global.com/


SOURCE

Share This Post